annual total liabilities:
$2.44B+$30.19M(+1.26%)Summary
- As of today (May 30, 2025), SRPT annual total liabilities is $2.44 billion, with the most recent change of +$30.19 million (+1.26%) on December 31, 2024.
- During the last 3 years, SRPT annual total liabilities has risen by +$215.47 million (+9.71%).
- SRPT annual total liabilities is now -11.23% below its all-time high of $2.74 billion, reached on December 31, 2022.
Performance
SRPT Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$2.32B-$112.77M(-4.63%)Summary
- As of today (May 30, 2025), SRPT quarterly total liabilities is $2.32 billion, with the most recent change of -$112.77 million (-4.63%) on March 1, 2025.
- Over the past year, SRPT quarterly total liabilities has increased by +$59.47 million (+2.63%).
- SRPT quarterly total liabilities is now -15.34% below its all-time high of $2.74 billion, reached on December 31, 2022.
Performance
SRPT quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SRPT Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.3% | +2.6% |
| 3 y3 years | +9.7% | +5.6% |
| 5 y5 years | +142.4% | +28.9% |
SRPT Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.2% | +9.7% | -15.3% | +5.6% |
| 5 y | 5-year | -11.2% | +142.4% | -15.3% | +28.9% |
| alltime | all time | -11.2% | >+9999.0% | -15.3% | >+9999.0% |
SRPT Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.32B(-4.6%) |
| Dec 2024 | $2.44B(+1.3%) | $2.44B(+2.4%) |
| Sep 2024 | - | $2.38B(+1.3%) |
| Jun 2024 | - | $2.35B(+3.7%) |
| Mar 2024 | - | $2.26B(-5.9%) |
| Dec 2023 | $2.41B(-12.3%) | $2.41B(+2.6%) |
| Sep 2023 | - | $2.35B(-1.6%) |
| Jun 2023 | - | $2.38B(+1.6%) |
| Mar 2023 | - | $2.35B(-14.4%) |
| Dec 2022 | $2.74B(+23.6%) | $2.74B(+0.7%) |
| Sep 2022 | - | $2.73B(+20.0%) |
| Jun 2022 | - | $2.27B(+3.2%) |
| Mar 2022 | - | $2.20B(-0.9%) |
| Dec 2021 | $2.22B(-0.1%) | $2.22B(+1.2%) |
| Sep 2021 | - | $2.19B(-3.6%) |
| Jun 2021 | - | $2.27B(+2.0%) |
| Mar 2021 | - | $2.23B(+0.3%) |
| Dec 2020 | $2.22B(+121.3%) | $2.22B(+17.7%) |
| Sep 2020 | - | $1.89B(+2.6%) |
| Jun 2020 | - | $1.84B(+2.1%) |
| Mar 2020 | - | $1.80B(+79.4%) |
| Dec 2019 | $1.00B(+64.7%) | $1.00B(+42.0%) |
| Sep 2019 | - | $707.27M(+9.0%) |
| Jun 2019 | - | $648.59M(+5.4%) |
| Mar 2019 | - | $615.33M(+0.9%) |
| Dec 2018 | $609.80M(+17.6%) | $609.80M(+12.3%) |
| Sep 2018 | - | $543.06M(-0.9%) |
| Jun 2018 | - | $548.11M(+4.7%) |
| Mar 2018 | - | $523.52M(+0.9%) |
| Dec 2017 | $518.75M(+493.4%) | $518.75M(+403.0%) |
| Sep 2017 | - | $103.13M(+42.5%) |
| Jun 2017 | - | $72.37M(-12.2%) |
| Mar 2017 | - | $82.39M(-5.7%) |
| Dec 2016 | $87.41M(+4.8%) | $87.41M(+11.1%) |
| Sep 2016 | - | $78.69M(-4.7%) |
| Jun 2016 | - | $82.61M(+11.0%) |
| Mar 2016 | - | $74.40M(-10.8%) |
| Dec 2015 | $83.44M(+76.1%) | $83.44M(+35.6%) |
| Sep 2015 | - | $61.52M(-7.3%) |
| Jun 2015 | - | $66.33M(+58.1%) |
| Mar 2015 | - | $41.95M(-11.5%) |
| Dec 2014 | $47.38M(+6.8%) | $47.38M(+44.2%) |
| Sep 2014 | - | $32.85M(-12.1%) |
| Jun 2014 | - | $37.39M(-19.5%) |
| Mar 2014 | - | $46.43M(+4.6%) |
| Dec 2013 | $44.38M(-45.4%) | $44.38M(-22.8%) |
| Sep 2013 | - | $57.49M(-39.4%) |
| Jun 2013 | - | $94.81M(-10.6%) |
| Mar 2013 | - | $106.06M(+30.4%) |
| Dec 2012 | $81.31M(+248.2%) | $81.31M(+41.1%) |
| Sep 2012 | - | $57.65M(+194.1%) |
| Jun 2012 | - | $19.60M(-39.9%) |
| Mar 2012 | - | $32.63M(+39.7%) |
| Dec 2011 | $23.35M(-52.1%) | $23.35M(-20.4%) |
| Sep 2011 | - | $29.33M(-26.3%) |
| Jun 2011 | - | $39.78M(-13.7%) |
| Mar 2011 | - | $46.11M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $48.79M(+34.1%) | $48.79M(+4.5%) |
| Sep 2010 | - | $46.70M(+16.1%) |
| Jun 2010 | - | $40.23M(+37.0%) |
| Mar 2010 | - | $29.35M(-19.4%) |
| Dec 2009 | $36.40M(+271.2%) | $36.40M(-20.2%) |
| Sep 2009 | - | $45.62M(+58.2%) |
| Jun 2009 | - | $28.83M(+104.1%) |
| Mar 2009 | - | $14.13M(+44.1%) |
| Dec 2008 | $9.80M(-20.0%) | $9.80M(-25.6%) |
| Sep 2008 | - | $13.18M(+16.2%) |
| Jun 2008 | - | $11.34M(-22.9%) |
| Mar 2008 | - | $14.69M(+19.9%) |
| Dec 2007 | $12.26M(+289.0%) | $12.26M(+5.3%) |
| Sep 2007 | - | $11.64M(+66.4%) |
| Jun 2007 | - | $6.99M(+60.9%) |
| Mar 2007 | - | $4.35M(+38.0%) |
| Dec 2006 | $3.15M(+14.7%) | $3.15M(+44.3%) |
| Sep 2006 | - | $2.18M(-3.6%) |
| Jun 2006 | - | $2.26M(+2.5%) |
| Mar 2006 | - | $2.21M(-19.6%) |
| Dec 2005 | $2.75M(+22.2%) | $2.75M(+8.9%) |
| Sep 2005 | - | $2.52M(+30.9%) |
| Jun 2005 | - | $1.93M(-15.4%) |
| Mar 2005 | - | $2.28M(+1.3%) |
| Dec 2004 | $2.25M(-40.0%) | $2.25M(+66.7%) |
| Sep 2004 | - | $1.35M(-37.7%) |
| Jun 2004 | - | $2.17M(-21.2%) |
| Mar 2004 | - | $2.75M(-26.7%) |
| Dec 2003 | $3.75M(-26.8%) | $3.75M(+62.5%) |
| Sep 2003 | - | $2.31M(+78.1%) |
| Jun 2003 | - | $1.30M(-20.0%) |
| Mar 2003 | - | $1.62M(-68.4%) |
| Dec 2002 | $5.12M(+56.1%) | $5.12M(+4.2%) |
| Sep 2002 | - | $4.92M(+24.3%) |
| Jun 2002 | - | $3.96M(-16.2%) |
| Mar 2002 | - | $4.72M(+43.9%) |
| Dec 2001 | $3.28M(+90.5%) | $3.28M(+107.5%) |
| Sep 2001 | - | $1.58M(-2.0%) |
| Jun 2001 | - | $1.61M(-0.2%) |
| Mar 2001 | - | $1.62M(-6.1%) |
| Dec 2000 | $1.72M(+72.3%) | $1.72M(+30.9%) |
| Sep 2000 | - | $1.32M(+19.2%) |
| Jun 2000 | - | $1.10M(+44.0%) |
| Mar 2000 | - | $767.00K(-23.3%) |
| Dec 1999 | $1.00M(-16.7%) | $1.00M(+42.9%) |
| Sep 1999 | - | $700.00K(+75.0%) |
| Jun 1999 | - | $400.00K(-42.9%) |
| Mar 1999 | - | $700.00K(-41.7%) |
| Dec 1998 | $1.20M(+140.0%) | $1.20M(0.0%) |
| Sep 1998 | - | $1.20M(+200.0%) |
| Jun 1998 | - | $400.00K(-20.0%) |
| Mar 1998 | - | $500.00K(0.0%) |
| Dec 1997 | $500.00K(+66.7%) | $500.00K(-37.5%) |
| Sep 1997 | - | $800.00K(-11.1%) |
| Jun 1997 | - | $900.00K(-74.3%) |
| Mar 1997 | - | $3.50M |
| Dec 1996 | $300.00K | - |
FAQ
- What is Sarepta Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual total liabilities year-on-year change?
- What is Sarepta Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total liabilities year-on-year change?
What is Sarepta Therapeutics annual total liabilities?
The current annual total liabilities of SRPT is $2.44B
What is the all time high annual total liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total liabilities is $2.74B
What is Sarepta Therapeutics annual total liabilities year-on-year change?
Over the past year, SRPT annual total liabilities has changed by +$30.19M (+1.26%)
What is Sarepta Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SRPT is $2.32B
What is the all time high quarterly total liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total liabilities is $2.74B
What is Sarepta Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SRPT quarterly total liabilities has changed by +$59.47M (+2.63%)